Works matching IS 15257304 AND DT 2022 AND VI 23 AND IP 6


Results: 9
    1
    2
    3

    Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 6, p. 522, doi. 10.1016/j.cllc.2022.06.001
    By:
    • Cardona, Andrés F.;
    • Ruiz-Patiño, Alejandro;
    • Recondo, Gonzalo;
    • Martín, Claudio;
    • Raez, Luis;
    • Samtani, Suraj;
    • Minata, José Nicolas;
    • Bautista Blaquier, Juan;
    • Enrico, Diego;
    • Burotto, Mauricio;
    • Ordóñez-Reyes, Camila;
    • Chamorro, Diego F.;
    • Garcia-Robledo, Juan Esteban;
    • Corrales, Luis;
    • Zatarain-Barrón, Zyanya Lucia;
    • Más, Luis;
    • Sotelo, Carolina;
    • Ricaurte, Luisa;
    • Santoyo, Nicolas;
    • Cuello, Mauricio
    Publication type:
    Article
    4
    5
    6
    7
    8

    Long-Term Survival of Patients With Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitor Monotherapy in Real-World Settings.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 6, p. 467, doi. 10.1016/j.cllc.2022.03.008
    By:
    • Taro Yoneda;
    • Takashi Sone;
    • Hayato Koba;
    • Kazuhiko Shibata;
    • Junya Suzuki;
    • Mayuko Tani;
    • Masaru Nishitsuji;
    • Koichi Nishi;
    • Takafumi Kobayashi;
    • Hiroki Shirasaki;
    • Tomoyuki Araya;
    • Toshiyuki Kita;
    • Kazumasa Kase;
    • Kenta Yamamura;
    • Nanao Terada;
    • Shingo Nishikawa;
    • Yuichi Tambo;
    • Hideharu Kimura;
    • Kazuo Kasahara
    Publication type:
    Article
    9